{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:46:34Z","timestamp":1786992394286,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jgyn.2013.09.030","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T22:45:53Z","timestamp":1383777953000},"page":"752-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Marqueurs s\u00e9riques et tumoraux ovariens dans le diagnostic des tumeurs ovariennes pr\u00e9sum\u00e9es b\u00e9nignes"],"prefix":"10.1016","volume":"42","author":[{"given":"N.","family":"Lahlou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2013.09.030_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13277-010-0049-1","article-title":"Ovarian tumor marker HE4\u00a0is differently expressed during the phases of the menstrual cycle in healthy young women","volume":"31","author":"Anastasi","year":"2010","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cncr.23577","article-title":"Combining a symptoms index with CA 125\u00a0to improve detection of ovarian cancer","volume":"113","author":"Andersen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","article-title":"Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses","volume":"103","author":"Tingulstad","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1373\/clinchem.2009.140855","article-title":"A recipe for proteomics diagnostic test development: the OVA1\u00a0test, from biomarker discovery to FDA clearance","volume":"56","author":"Fung","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4\u00a0and CA125\u00a0for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2012.10.036","article-title":"Human epididymis protein 4\u00a0for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis","volume":"167","author":"Lin","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4\u00a0vs. carbohydrate antigen 125\u00a0for ovarian cancer diagnosis: a systematic review","volume":"66","author":"Ferraro","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2407-12-258","article-title":"Does risk of ovarian malignancy algorithm excel human epididymis protein 4\u00a0and CA125\u00a0in predicting epithelial ovarian cancer: a meta-analysis","volume":"12","author":"Li","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/CCLM.2011.075","article-title":"The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?","volume":"49","author":"Montagnana","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4\u00a0in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00404-013-2722-2","article-title":"Evaluation of HE4\u00a0as an extrabiomarker to CA125\u00a0to improve detection of ovarian carcinoma: is it time for a step forward?","volume":"288","author":"Azzam","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0065","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/IGC.0b013e318249bee7","article-title":"Serum HE4\u00a0as a useful biomarker in discriminating ovarian cancer from benign pelvic disease","volume":"22","author":"Zheng","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-8-11","article-title":"Significance of HE4\u00a0estimation in comparison with CA125\u00a0in diagnosis of ovarian cancer and assessment of treatment response","volume":"8","author":"Hamed","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0075","first-page":"4137","article-title":"HE4\u00a0and ROMA index in Czech postmenopausal women","volume":"32","author":"Novotny","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/IGC.0b013e318234f852","article-title":"The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis","volume":"22","author":"Kadija","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2012.11.026","article-title":"Comparison of HE4, CA125\u00a0and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome","volume":"128","author":"Sandri","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2013.01.018","article-title":"A comparison between an ultrasound based prediction model (LR2) and the Risk of Ovarian Malignancy Algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass","volume":"129","author":"Kaijser","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2009.10.087","article-title":"Use of Symptom index, CA125\u00a0and HE4\u00a0to predict ovarian cancer","volume":"116","author":"Andersen","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.6061\/clinics\/2012(05)06","article-title":"A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses","volume":"67","author":"Anton","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0105","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ejca.2011.12.003","article-title":"Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses","volume":"48","author":"Van Gorp","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0110","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s13277-012-0440-1","article-title":"An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions","volume":"33","author":"Macuks","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004347-198203000-00001","article-title":"Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121\u00a0primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies","volume":"1","author":"Charpin","year":"1982","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0090-8258(89)90628-8","article-title":"Tissue expression of CA 125\u00a0in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9\u00a0and CEA","volume":"32","author":"Neunteufel","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0125","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1447-0756.2011.01833.x","article-title":"Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma","volume":"38","author":"Kataoka","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/172460080902400108","article-title":"Elevated CA 19-9\u00a0levels in mature cystic teratoma of the ovary","volume":"24","author":"Kyung","year":"2009","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00404-008-0688-2","article-title":"Tumor markers in mature cystic teratomas of the ovary","volume":"279","author":"Emin","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1525-1438.2006.00284.x","article-title":"CA19-9\u00a0may have clinical significance in mature cystic teratomas of the ovary","volume":"16","author":"Dede","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/gyno.1993.1026","article-title":"Serum and tissue measurements of CA72-4\u00a0in ovarian cancer patients","volume":"48","author":"Negishi","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0150","first-page":"459","article-title":"Women with a pelvic mass: indicators of malignancy","volume":"22","author":"Balbi","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.jgyn.2013.09.030_bib0155","first-page":"A4331","article-title":"Combination of cancer antigen 125\u00a0and carcinoembryonic antigen can improve ovarian cancer diagnosis","volume":"58","author":"S\u00f8rensen","year":"2011","journal-title":"Dan Med Bul"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231513002767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231513002767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T23:26:55Z","timestamp":1564615615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231513002767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0368231513002767"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2013.09.030","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marqueurs s\u00e9riques et tumoraux ovariens dans le diagnostic des tumeurs ovariennes pr\u00e9sum\u00e9es b\u00e9nignes","name":"articletitle","label":"Article Title"},{"value":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgyn.2013.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}